In vitro analysis of 4-methylumbelliferone as a sole carbon source for Lactobacillus helveticus 2126

B. Madhoolika, N. V. Anil Kumar, S. Balaji

Research output: Contribution to journalArticle

Abstract

In the recent years, 4-methylumbelliferone (4-MU) has been gaining importance, both as an anti-cancer agent and as a dietary supplement. The aim of this study was to determine the effectiveness of 4-MU as a carbon source for potential probiotic bacteria Lactobacillus helveticus 2126. For this purpose, a series of plate assays and infrared spectroscopy (FTIR) were used for 4-MU before and after the treatment with L. helveticus 2126. The plate assays indicated an initial inhibition followed by utilization of 4-MU that stimulated bacterial growth. A significant shift was observed in the FTIR peaks, which also have suggested possible extracellular activity of the bacteria for 4-MU utilization. Significance and Impact of the Study: 4-Methylumbelliferone (4-MU) is a widely used chloretic and is currently under research for treating colon cancer. Preliminary studies suggest that it has the potential to be used as an effective and sustainable prebiotic for the human microbiome, as it can be naturally obtained from plants. This manuscript describes the effectiveness of 4-MU as a carbon source for the probiotic bacteria Lactobacillus helveticus. Our study also suggests the role of bacterial superoxide dismutase in transforming 4-MU as a possible prebiotic for the human microbiome.

Original languageEnglish
Pages (from-to)249-255
Number of pages7
JournalLetters in Applied Microbiology
Volume65
Issue number3
DOIs
Publication statusPublished - 01-09-2017

Fingerprint

Hymecromone
Lactobacillus helveticus
Carbon
Prebiotics
Microbiota
Probiotics
Fourier Transform Infrared Spectroscopy
Bacteria
In Vitro Techniques
Dietary Supplements
Colonic Neoplasms
Superoxide Dismutase
Spectrum Analysis

All Science Journal Classification (ASJC) codes

  • Applied Microbiology and Biotechnology

Cite this

@article{6bd294c8f0af48b59d058371b84a21e3,
title = "In vitro analysis of 4-methylumbelliferone as a sole carbon source for Lactobacillus helveticus 2126",
abstract = "In the recent years, 4-methylumbelliferone (4-MU) has been gaining importance, both as an anti-cancer agent and as a dietary supplement. The aim of this study was to determine the effectiveness of 4-MU as a carbon source for potential probiotic bacteria Lactobacillus helveticus 2126. For this purpose, a series of plate assays and infrared spectroscopy (FTIR) were used for 4-MU before and after the treatment with L. helveticus 2126. The plate assays indicated an initial inhibition followed by utilization of 4-MU that stimulated bacterial growth. A significant shift was observed in the FTIR peaks, which also have suggested possible extracellular activity of the bacteria for 4-MU utilization. Significance and Impact of the Study: 4-Methylumbelliferone (4-MU) is a widely used chloretic and is currently under research for treating colon cancer. Preliminary studies suggest that it has the potential to be used as an effective and sustainable prebiotic for the human microbiome, as it can be naturally obtained from plants. This manuscript describes the effectiveness of 4-MU as a carbon source for the probiotic bacteria Lactobacillus helveticus. Our study also suggests the role of bacterial superoxide dismutase in transforming 4-MU as a possible prebiotic for the human microbiome.",
author = "B. Madhoolika and {Anil Kumar}, {N. V.} and S. Balaji",
year = "2017",
month = "9",
day = "1",
doi = "10.1111/lam.12772",
language = "English",
volume = "65",
pages = "249--255",
journal = "Letters in Applied Microbiology",
issn = "0266-8254",
publisher = "Wiley-Blackwell",
number = "3",

}

In vitro analysis of 4-methylumbelliferone as a sole carbon source for Lactobacillus helveticus 2126. / Madhoolika, B.; Anil Kumar, N. V.; Balaji, S.

In: Letters in Applied Microbiology, Vol. 65, No. 3, 01.09.2017, p. 249-255.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In vitro analysis of 4-methylumbelliferone as a sole carbon source for Lactobacillus helveticus 2126

AU - Madhoolika, B.

AU - Anil Kumar, N. V.

AU - Balaji, S.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - In the recent years, 4-methylumbelliferone (4-MU) has been gaining importance, both as an anti-cancer agent and as a dietary supplement. The aim of this study was to determine the effectiveness of 4-MU as a carbon source for potential probiotic bacteria Lactobacillus helveticus 2126. For this purpose, a series of plate assays and infrared spectroscopy (FTIR) were used for 4-MU before and after the treatment with L. helveticus 2126. The plate assays indicated an initial inhibition followed by utilization of 4-MU that stimulated bacterial growth. A significant shift was observed in the FTIR peaks, which also have suggested possible extracellular activity of the bacteria for 4-MU utilization. Significance and Impact of the Study: 4-Methylumbelliferone (4-MU) is a widely used chloretic and is currently under research for treating colon cancer. Preliminary studies suggest that it has the potential to be used as an effective and sustainable prebiotic for the human microbiome, as it can be naturally obtained from plants. This manuscript describes the effectiveness of 4-MU as a carbon source for the probiotic bacteria Lactobacillus helveticus. Our study also suggests the role of bacterial superoxide dismutase in transforming 4-MU as a possible prebiotic for the human microbiome.

AB - In the recent years, 4-methylumbelliferone (4-MU) has been gaining importance, both as an anti-cancer agent and as a dietary supplement. The aim of this study was to determine the effectiveness of 4-MU as a carbon source for potential probiotic bacteria Lactobacillus helveticus 2126. For this purpose, a series of plate assays and infrared spectroscopy (FTIR) were used for 4-MU before and after the treatment with L. helveticus 2126. The plate assays indicated an initial inhibition followed by utilization of 4-MU that stimulated bacterial growth. A significant shift was observed in the FTIR peaks, which also have suggested possible extracellular activity of the bacteria for 4-MU utilization. Significance and Impact of the Study: 4-Methylumbelliferone (4-MU) is a widely used chloretic and is currently under research for treating colon cancer. Preliminary studies suggest that it has the potential to be used as an effective and sustainable prebiotic for the human microbiome, as it can be naturally obtained from plants. This manuscript describes the effectiveness of 4-MU as a carbon source for the probiotic bacteria Lactobacillus helveticus. Our study also suggests the role of bacterial superoxide dismutase in transforming 4-MU as a possible prebiotic for the human microbiome.

UR - http://www.scopus.com/inward/record.url?scp=85026286367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026286367&partnerID=8YFLogxK

U2 - 10.1111/lam.12772

DO - 10.1111/lam.12772

M3 - Article

VL - 65

SP - 249

EP - 255

JO - Letters in Applied Microbiology

JF - Letters in Applied Microbiology

SN - 0266-8254

IS - 3

ER -